BO1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - BioCryst Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 8.068 EUR 2.39% Market Closed

Market Cap: €2.6B

B	BioCryst Pharmaceuticals Inc XMUN:BO1	US
I	Informa PLC F:IEA	UK
I	IHS Markit Ltd F:0M3	UK
R	Richter Gedeon Vegyeszeti Gyar Nyrt XMUN:RIG2	HU
	Fastenal Co NASDAQ:FAST	US
S	Sturm Ruger & Company Inc F:ST2	US
	Banco Santander SA F:BSD2	ES
C	CENIT AG SWB:CSH	DE
J	Japan Display Inc XMUN:1J4	JP
I	Imperial Brands PLC F:ITB	UK
V	Vifor Pharma AG F:G2AB	CH
	Tiny Ltd XTSX:TINY	CA

Profitability Summary

BioCryst Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

98%

Gross Margin is Increasing

97% > 98%

Exceptional Operating Margin

36%

Negative 3Y Average Operating Margin

-2%

Operating Margin is Increasing

-37% > 36%

Negative Net Margin

-52%

Negative 3Y Average Net Margin

-30%

Net Margin is Increasing

-79% > -52%

Exceptional Free Cash Flow Margin

35%

Negative 3Y Average Free Cash Flow Margin

-6%

Free Cash Flow Margin is Increasing

-40% > 35%

Exceptional ROE

91%

Exceptional 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.